Ontruzant 440 mg (Trastuzumab POWDER FOR SOLUTION) 440 MG

Ontruzant 440 mg is a powder for solution used in intravenous therapy. It contains trastuzumab, a monoclonal antibody for targeted treatment. This medication is commonly used in cancer therapy.

Strength

440 MG

Manufacturer / TM Owner

SAMSUNG BIOEPIS CO., LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ontruzant 440 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins on cancer cells, helping to slow or stop their growth. This medication is often used in combination with other cancer treatments.

Side Effects

Common effects of Ontruzant 440 mg may include fatigue, nausea, and injection site reactions. Some individuals may experience more severe side effects, such as fever or difficulty breathing. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Ontruzant 440 mg should be handled with care and administered by a healthcare professional. It is important to follow proper storage and preparation guidelines. Inform your healthcare provider about any allergies or medical conditions before use.

Avoid Interactions

Ontruzant 440 mg may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Always follow the advice of a healthcare professional.

Frequently Asked Questions

Ontruzant 440 mg is used in the treatment of certain types of cancer, often in combination with other therapies.

Ontruzant 440 mg is administered intravenously as a solution prepared from the powder.

Common side effects may include fatigue, nausea, and reactions at the injection site.

Ontruzant 440 mg may interact with other medications, so it is important to consult a healthcare provider.

Ontruzant 440 mg is manufactured by Samsung Bioepis Co., Ltd.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.